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Summary 
Genomic imprinting directs the allele-specific marking and expression of loci according to 
their parental origin. Differential DNA methylation at imprinted control regions (ICRs) is 
established in gametes and, although largely preserved through development, can be 
experimentally reset by fusing somatic cells with embryonic germ cell (EGC) lines. Here, we 
show that the Ten-Eleven Translocation proteins Tet1 and Tet2 participate in the efficient 
erasure of imprints in this model system. The fusion of B cells with EGCs initiates 
pluripotent reprogramming, in which rapid re-expression of Oct4 is accompanied by an 
accumulation of 5-hydroxymethylcytosine (5hmC) at several ICRs. Tet2 was required for the 
efficient reprogramming capacity of EGCs, whereas Tet1 was necessary to induce 5-
methylcytosine oxidation specifically at ICRs. These data show that the Tet1 and Tet2 
proteins have discrete roles in cell-fusion-mediated pluripotent reprogramming and imprint 
erasure in somatic cells. 
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Introduction 
During mammalian embryogenesis, the genome encounters two waves of global DNA 
demethylation. The first wave enables the genomes of the contributing gametes to reattain 
pluripotency, a state that, although transient within the inner cell mass of the mouse 
blastocyst, is susceptible to in vitro immortalization through the generation of embryonic 
stem cell (ESC) lines. A second wave of demethylation occurs within primordial germ cells 
(PGCs), a population that originates from the pluripotent epiblast. Following their 
specification beginning at embryonic day (E) 7.25 (Ginsburg et al., 1990), PGCs migrate 
through the dorsal mesentry to the genital ridges (Hayashi and Surani, 2009). Demethylation 
of imprinted genes occurs after PGCs enter the genital ridge between E11.5 and E13.5 
(Hajkova et al., 2002; Hayashi and Surani, 2009). Self-renewing pluripotent embryonic germ 
cell (EGC) lines can be derived from PGCs from E8.5 onward (Tada et al., 1998; Durcova-
Hills et al., 2006; Leitch et al., 2010). Although EGC lines share many features with ESCs 
(Mise et al., 2008; Hayashi and Surani, 2009; Leitch et al., 2010), they commonly show DNA 
hypomethylation at imprinted domains, a characteristic that probably reflects their PGC 
origin (Labosky et al., 1994). 
How DNA methylation is reversed is a central question in epigenetic reprogramming 
(Hayashi and Surani, 2009; Chen and Riggs, 2011). Loss of 5mC from the genome is 
postulated to occur either through active removal or conversion of 5mC in a manner that does 
not require DNA synthesis or by passive demethylation, a process in which 5mC or its 
derivatives are progressively diluted during DNA replication. Among the candidate processes 
and factors implicated in the active conversion of 5mC to its unmodified form are 
bifunctional 5mC-specific DNA glycosylases (such as ROS1 and DME) that have been 
detected in plants (Morales-Ruiz et al., 2006) but not in metazoans. Several enzymes catalyze 
the deamination or oxidation of 5mC in vertebrates, including members of the AID, 
APOBEC, and Tet1–Tet3 families, respectively (Muramatsu et al., 2000; Tahiliani et al., 
2009; Ito et al., 2010). Thymine DNA glycosylases that excise G-T mismatches or 
formylcytosine and carboxycytosine from DNA (Ito et al., 2011; Maiti and Drohat, 2011) and 
initiate the base excision repair pathway (Wu and Zhang, 2010) have also been implicated in 
DNA methylation loss. Other pathways, including nucleotide excision repair and the 
associated factor Gadd45a, may also participate in active DNA demethylation (Barreto et al., 
2007). From these studies, a wide range of mechanisms for achieving demethylation have 
been proposed that may operate in vivo (Rai et al., 2008; Guo et al., 2011; Shearstone et al., 
2011), in ESCs or during early preimplantation development (Inoue and Zhang, 2011; 
Williams et al., 2011a; Wu and Zhang, 2011; Xu et al., 2011), within the germline (Hajkova 
et al., 2010; Popp et al., 2010), and during experimental reprogramming (Bhutani et al., 
2010). Despite this, there is no consensus as to whether multiple alternative routes of 
demethylation act in vivo and in vitro according to context or whether a single universal 
mechanism predominates (Wu and Zhang, 2010; Teperek-Tkacz et al., 2011). 
During cell-fusion-mediated reprogramming, lineage identity is reset and genome 
methylation is modified (Tada et al., 1997; Pereira et al., 2008; Yamanaka and Blau, 2010). 
Fusion of differentiated cells, such as lymphocytes or fibroblasts, with mouse ESCs results in 
heterokaryon (2n + 2n) formation, in which both nuclei are initially discrete. Later, these 
nuclei fuse and generate tetraploid (4n) hybrids that can proliferate extensively in culture. 
Upon heterokaryon and hybrid formation, gene expression of the differentiated cell is 
gradually extinguished in favor of pluripotency (Tada et al., 2001; Pereira et al., 2010; 
Piccolo et al., 2011). Although ESCs and EGCs can both dominantly reprogram in such 
assays, EGCs alone have been shown to induce DNA demethylation and erasure of the 
genomic imprints within the somatic genome upon hybrid formation (Tada et al., 1997). 
Here, we revisit these pioneering experiments to examine the early molecular events that 
underlie imprint erasure in somatic cell reprogramming in heterokaryons and hybrids. We 
show that Tet2 is important for the rapid re-expression of pluripotency-associated genes 
induced after fusion with EGCs and that it mediates the efficient oxidation of 5mC at the 
somatic OCT4 locus. Tet1, in contrast, was required for 5hmC accumulation at ICRs. Our 
studies reveal key differences in the factors and kinetics regulating the demethylation of the 
somatic genome and suggest that DNA replication-dependent and -independent mechanisms 
probably cooperate to erase imprints in this model system. 
Go to: 
Results 
Loss of DNA Methylation at ICRs Is Induced in Somatic Cell Hybrids 
Generated with EGCs 
Previous studies have shown that fusion of mouse thymocytes with EGC lines 58G and 55G 
generated hybrids, in which the T cell genome was hypomethylated at ICRs and a model 
imprinted transgene was reactivated (Tada et al., 1997). To verify and extend these studies, 
we performed sodium bisulfite analysis to quantify DNA methylation at the mouse H19/Igf2, 
Peg3, and Dlk1/Gtl2 ICRs in EGCs, in a puromycin-resistant mouse B line that carries a 
silent Oct4-GFP transgene (mB), and in reprogrammed hybrids isolated 21 days after fusion 
between these cell types on the basis of puromycin resistance and Oct4-GFP re-expression 
(GFP+) (Figure 1A, and Figure S1A available online). Hybrid clones were also generated 
with the use of ESCs for comparison, and both sets of hybrids were checked for assessment 
of karyotypic fidelity. Bisulfite analysis confirmed that several imprinted domains were 
hypomethylated in EGCs (<1% Peg3, 13% H19/Igf2, and 24% Dlk1/Gtl2) in comparison to 
mB, in which approximately half of alleles were methylated (50%–61%, Figure 1B). Hybrids 
formed with EGCs showed a reduction in DNA methylation at H19/Igf2 (from 30% of alleles 
at day 0 to 1.5% by day 21), Peg3 (from 34% to 11%), and Dlk1/Gtl2 (43% to 18%) 
(Figure 1C, upper panels). Hybrids generated with ESCs did not show substantive changes in 
DNA methylation at any of these loci (Figure 1C, lower panels). The selective loss of 5mC at 
ICRs in EGC-derived hybrids was confirmed by HpaII restriction digests (Figure S1B) and 
was verified with the use of multiple independently isolated hybrid clones (Figure S1C). In 
addition, B cell hybrids generated after fusing mB cells with female Pgk12 ESCs (Zvetkova 
et al., 2005), or ESCs lacking Dnmt1 (Li et al., 1992) or Dnmt3a and Dnmt3b (Chen et al., 
2003), did not show comparable reductions in methylation at imprinted regions, despite each 
of the parental ESC lines being hypomethylated (Figures S1D and S1E). These data show 
that EGCs induce DNA demethylation at imprinting domains within the somatic genome 
upon cell-fusion-mediated reprogramming, whereas ESC lines with a similarly low level of 
endogenous DNA methylation do not. 
  
Figure 1 
 
Reprogrammed Hybrids Generated with Mouse EGCs Show Reduced DNA Methylation at Imprinted 
Loci 
(A) Oct4-GFP re-expressing (GFP+) hybrids were generated by fusing puromycin-resistant (PurR) 
mouse BOct4-GFP cells (gray) with mouse EGCs or ESCs (white). 
 
(B) Bisulfite analysis of H19/Igf2, Peg3, and Gtl2/Dlk1 loci in parental cells before fusion where 
unmethylated and methylated CpG are shown as open and closed circles, respectively. 
 
(C) Bisulfite analysis of cells before fusion (day 0) and after hybrid formation (day 21). Hybrids 
generated with ESCs were used as controls. ICR positions are marked in black, red bars indicate the 
primer-amplified PCR products, and percentage methylation levels are shown in red. 
 
(D) Number of cells in hybrid colonies generated by fusing mB and mEGCs. Values for individual 
colonies (black squares) and average cell number (red open circles) are shown at each time point. 
 
(E) Bisulfite analysis of H19/Igf2 locus in samples 7 and 12 days after fusion of mEGCs and mBOct4-
GFP cells. 
To investigate the kinetics of this loss of DNA methylation, we fused transgenic Oct4-GFP 
mB cells with EGCs and plated them at low density so that the timing of Oct4-GFP re-
expression and cell division could be assessed with microscopy. During the first couple of 
days after fusion, individual heterokaryons were detected. Thereafter, cells re-expressing 
Oct4-GFP were observed and hybrid colonies containing increasing numbers of cells were 
recorded at successive days (Figure 1D) so that, by days 6–7, most clones had undergone at 
least five rounds of cell division. Bisulfite analysis of reprogrammed (Oct4-GFP+) hybrid 
clones isolated at this stage showed substantial DNA methylation remaining at the H19/Igf2 
locus (43%, day 7) that declined as these clones were propagated further (17%, day 12; <5%, 
day 21) (Figures 1E and S1C). These results suggested that EGC-induced DNA 
demethylation at imprinted regions might be slower or less efficient than EGC-induced 
demethylation and reactivation of the Oct4 locus. 
Demethylation and Re-expression of Maternal Peg1 
To investigate this further, we established a puromycin-resistant, dual-reported mouse B cell 
line (2rB) that carried a maternal LacZ knockin allele of Peg1 (Lefebvre et al., 1998) in 
addition to the Oct4-GFP transgene (Yeom et al., 1996). This allowed for the coordinate 
monitoring of events associated with pluripotent reprogramming (Oct4-GFP expression) and 
Peg1-LacZ reactivation (β-galactosidase activity), as depicted in Figure 2A. Mouse 2rB cells 
were fused with EGCs in a 1:1 ratio and plated at low density. Oct4-GFP was detected from 
day 3 onward in heterokaryons (Figure S2A) as well as in newly formed two-cell hybrids. 
Given that DNA synthesis by somatic nuclei is induced after fusion with ESCs (Tsubouchi 
et al., 2013), we asked whether 2rB cells undergo DNA synthesis when fused with EGCs. For 
this, heterokaryons were pulsed with BrdU (45 min, 100 μM) 24 hr after fusion and cultured 
for an additional 2 days before BrdU incorporation was revealed among the reprogrammed 
(Oct4-GFP+) cells. We found that most GFP+ heterokaryons identified at day 3 (>75%) had 
incorporated a BrdU pulse applied 24 hr after fusion (illustrated in Figure 2B), similar to 
results obtained with ESCs (Tsubouchi et al., 2013). Peg1-regulated β-galactosidase activity 
was not detected in any cells 3, 6, or 12 days after fusion (Figures 2C and 2D), consistent 
with the reported low level of expression of Peg1 in pluripotent stem cells (Lefebvre et al., 
1998). Peg1M-βgal expression was, however, evident in hybrid cells that had been induced to 
differentiate by leukemia inhibitory factor (LIF) withdrawal (Figures 2E and 2F) and, 
importantly, was uniquely detected in 2rB hybrids generated with EGCs, rather than parallel 
cultures derived from ESCs (Figure 2F). These data demonstrated that EGCs were able to 
functionally reset the maternally derived (silent) Peg1 imprint in the B cell genome. 
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Early Pluripotent Reprogramming and Late Re-Expression of an Imprinted Peg1 Allele in Mouse 
B Cells After Fusion with EGCs 
(A) Reprogramming and imprint erasure was modeled with the use of mouse 2rB cells 
(puromycin-resistant Oct4-GFP B cells containing a maternal LacZ knock-in allele of Peg1 
[Peg1M-βgal]). 
 
(B) A heterokaryon between EGCs and 2rB cells showing BrdU incorporation (pulse-labeled at 
day 1, red), Oct4 re-expression (Oct4-GFP+ day 3, green), and DAPI staining (blue). 
 
(C) A representative Oct4-GFP+ (green) EGC-2rB heterokaryon is shown in which β-
galactosidase activity was not detected at day 3. 
 
(D) Hybrid colonies at day 12 remain Oct4-GFP+ but lack β-galactosidase activity. 
 
(E) Kinetic analysis of mOct4 (green) and mPeg1 (blue) gene expression in 2rB × mEGC hybrids 
following LIF withdrawal. Mean and SD of three independent experiments are shown, and values 
were calculated relative to UBC. 
 
(F) Maternally derived Peg1-βgal activity (blue) is selectively detected in 2rB × EGC hybrids after 
differentiation induced by LIF withdrawal. 
 
(G) Bisulfite analysis showing the kinetics of DNA methylation loss at Peg1 in 2rB cells following 
fusion with EGCs. Parental cells before fusion (left panel) and in Oct4-GFP+ 2rB × mEGC 
hybrids collected 7, 12, and 21 days after fusion (right panel). Unmethylated (closed circles) and 
methylated (open circles) CpGs are indicated and the percentage methylation is shown in red. Red 
bars indicate the position of primer-amplified PCR product relative to the Peg1-βgal locus. 
 
(H) Bisulfite analysis of DNA methylation at Line1 repetitive elements in parental 2rB and 
mEGCs before and after hybrid formation. 
To investigate the kinetics of this reversal, we examined DNA methylation at the Peg1-LacZ 
locus among Oct4-GFP+ hybrid cells that were harvested at sequential times after fusion. As 
shown in Figure 2G, bisulfite analysis revealed that the Peg1 marker locus remained 
substantially methylated in hybrid cells isolated at day 7 (29%) but declined as these cells 
were further cultured (15% at day 12, 7% at day 21). Loss of methylation at the Peg1-LacZ 
locus in EGC-derived hybrids was confirmed with HpaII digests (Figure S2B). Altogether, 
these results suggest that demethylation of somatic Peg1 was induced much more slowly than 
demethylation occurring at the Oct4 locus. 
To address whether EGC-induced reprogramming erased DNA methylation at additional sites 
in the somatic genome, we examined the methylation status of long interspersed element 
(LINE) repeats in reprogrammed 2rB hybrids generated with either EGCs or ESCs. As shown 
in Figures 2H and S2C, Line1 repeats were hypomethylated in 2rB hybrids generated with 
EGCs but remained partially methylated in hybrids formed with ESCs. This suggests that the 
potent capacity of EGCs to induce demethylation was not restricted to pluripotency-
associated genes and ICRs but also extended to other sites of DNA methylation within the 
somatic genome. 
Given that DNA hypomethylation could result from failures in maintaining DNA methylation 
during cell division, we compared the expression of the DNA maintenance methyltransferase 
Dnmt1, the de novo methyltransferases Dnmt3a and Dnmt3b, and the tethering factor Uhrf1 
in the EGC lines 55G and 58G and in ESL21 ESCs. Gene expression and western blotting 
analysis confirmed that these factors were present in both EGCs and ESCs (Figures S3A and 
S3B, respectively). These cell lines also expressed comparable levels of pluripotency-
associated genes (Figure S3C). Fluorescence microscopy confirmed a similar distribution of 
Dnmt1 and Uhrf1 proteins within mouse EGCs and ESCs (Figures S3D and S3E, 
respectively). We noted a slight trend for increasing ICR hypomethylation with EGC passage 
(Figure S3F), suggesting that cell division in culture might either directly promote a loss of 
DNA methylation or select for cells with increased hypomethylation. 
Altered 5mC Levels at Imprinted Domains in EGC Heterokaryons 
To investigate how EGCs induced the remodeling of a somatic genome during 
reprogramming, we generated interspecies heterokaryons using human B cells. This 
established approach uses human-specific primer sets, antibodies, and probes in order to 
discriminate the earliest events that occur in the somatic (human) nucleus after cell fusion 
(Pereira et al., 2008) (Figure 3A). Fusion of human B cells (hB) with mouse EGCs (1:1) 
induced the expression of human pluripotent gene transcripts (OCT4, NANOG, and CRIPTO) 
at comparable levels and with similar kinetics as those in fusions generated with mouse ESCs 
(Figure 3B). Before evaluating DNA methylation at imprinted domains, we began by 
sequencing the human H19/IGF2 domain in our human B cell clone and identified a SNP 
within the ICR that could discriminate the 5mC-containing (paternal) allele from the 
unmodified maternal allele (Figure 3C). Bisulfite analysis confirmed that methylated 
H19/IGF2 DNA accounted for approximately 40% of the hB sample before fusion and 
originated predominantly from the paternal allele. In samples 48 and 72 hr after fusion, most 
H19/IGF2 DNA sequences detected after bisulfite conversion were apparently unmethylated 
(99% and 90%, respectively; Figure 3D, left panels). SNP analysis revealed that this 
surprising result reflected a strong preference in the detection of the unmodified maternal 
allele rather than bona fide changes to the methylated paternal allele (Figure 3D, allelic origin 
[A/O]). Importantly, in parallel fusions performed with hB and ESCs (Figure 3D, right 
panels), this bias was not seen: methylated H19/IGF2 alleles accounted for 42% of the 
bisulfite converted hB sample before fusion and 38% and 42% at 48 and 72 hr after 
heterokaryon formation, respectively. Biased detection of maternally derived H19/IGF2 
alleles was therefore selective for reprogramming induced by EGCs. 
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Detection of Paternally Derived H19/IGF2 Alleles by Bisulfite Analysis Is Selectively 
Compromised in EGC-Induced Heterokaryon 
(A) Transient heterokaryons formed between human B cells (gray) and mouse EGCs or 
ESCs (white) were generated 48–72 hr after fusion (dashed red box). 
 
(B) Quantitative RT-PCR (qRT-PCR) analysis of human OCT4, NANOG, and CRIPTO 
expression by human B-lymphocytes before (0 hr), and 48 hr and 72 hr after fusion with 
either EGCs (black histograms) or ESCs (white histograms). Results are the mean and SE 
of five independent experiments where values were normalized to GADPH. 
 
(C) Sequencing analysis of human H19/IGF2 in bisulfite converted DNA isolated from a 
human B cell clone (hB). Maternally (M, red circle) and paternally (P, gray circle) derived 
alleles are distinguished by a thymidine-adenine single nucleotide polymorphism (SNP). 
Bisulfite analysis of hB samples where open and closed circles represent unmethylated and 
methylated CpGs, respectively, and the allelic origin (A/O) of H19/IGF2 alleles is indicated 
in red (maternal) or gray (paternal). 
 
(D) Bisulfite analysis of H19/IGF2 methylation in hB heterokaryons formed with mEGCs 
(left) or mESCs (right). 
Evidence that 5mC Is Rapidly Converted to 5hmC at Several ICRs in the 
Somatic Genome after Fusion with EGCs 
Impaired detection of methylated, paternally derived human H19/IGF2 alleles in bisulfite 
assays of EGC-heterokaryons was consistent in repeat experiments (not shown). We reasoned 
that this could reflect an accumulation of 5hmC at the H19/IGF2 locus given that previous 
studies had shown that 5hmC (but not 5mC) reacts with sodium bisulfite to yield cytosine 5-
methylenesulfonate (CMS) that can stall DNA polymerase and result in inefficient 
amplification by Taq polymerase (Huang et al., 2010). To explore this possibility, we used 
two different restriction enzyme digest protocols to compare levels of 5hmC and unmodified 
cytosine at OCT4 and at several human ICRs before and after heterokaryon formation with 
either EGCs or ESCs. In the first approach, pretreatment of samples with T4 
glucosyltransferase (which selectively protects 5hmC-containing DNA template from MspI 
digestion) was used to estimate 5hmC abundance (Figure 4A, left panel I). Using this 
strategy, we detected increased MspI resistance at the human OCT4 locus (Figure 4B) and at 
each of the human ICRs examined (H19/IGF2, SNRPN/SNURF, and PEG3; Figure 4D) in 
samples harvested 48 and 72 hr after fusion with EGCs (black histograms). This increase in 
5hmC at human ICRs was not evident in heterokaryons formed with ESCs (Figures 4D, white 
histograms), although increased MspI resistance consistent with remodeling of this locus in 
ESC-mediated pluripotent reprogramming was seen at OCT4 (Figure 4B, white histograms). 
These results, along with the bisulfite results shown previously, confirmed that EGCs 
selectively induced the accumulation of 5hmC at imprinted domains within the somatic 
genome. 
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Evidence that 5hmC Levels Increase at ICRs in Somatic Cells after Fusion with EGCs 
(A) Detection of 5hmC (I) and unmodified cytosine (II) in human heterokaryon samples. 
Genomic DNA was divided and was either treated with T4-β-glucosyltransferase, which 
binds glucose groups selectively at 5hmC sites (red asterisk) and creates 5hgmC (open 
hexagon, left), or left untreated (H2O). Samples were digested with MspI (which does not 
digest 5hgmC) or left undigested (H2O), and the abundance of locus-specific DNA in each 
was compared by qPCR. In strategy II, unmodified (C) and modified CpG (5mC and 5hmC) 
levels were evaluated by HpaII digestion (right); DNA samples were treated with HpaII 
(which does not cut 5mC and 5hmC), left undigested (H2O), or treated with MspI (which 
cuts both and provides a positive control). The abundance of locus-specific DNA within each 
of these samples was estimated by qPCR and used to calculate the percentage of HpaII 
resistance. 
 
(B) Levels of 5hmC at OCT4 in hB cells before (0 hr), and 48 hr and 72 hr after fusion with 
mouse EGCs (black bars) or ESCs (white bars) are shown as the mean and SE of three to five 
independent experiments. 
 
(C) HpaII digestion analysis of OCT4 in hB lymphocytes before (0 hr) and 48 hr and 72 hr 
after fusion with EGCs (closed circles) or ESCs (open circles) are shown. Red bars mark the 
position of primer-amplified PCR products derived from the promoter (right) and 
downstream of the TSS (left), and values represent the mean and SE of three to five 
independent experiments. **, p value < 0.005 calculated with Student’s t test. 
 
(D) Detection of 5hmC at H19/IGF2, PEG3, and SNRPN/SNURF was evaluated in genomic 
DNA from human B cells before (0 hr), and 48 or 72 hr after fusion with EGCs (black 
histograms) or ESCs (white histograms). The position of ICRs is indicated in black, and red 
bars mark the position of primer-amplified PCR product. The values shown are the mean and 
SE of three to five independent experiments. *, p value < 0.05; **, p value < 0.005 calculated 
with Student’s t test. 
 
(E) HpaII digests of H19/IGF2, PEG3, and SNRPN/SNURF ICRs in hB lymphocytes before 
(0 hr), and 48 and 72 hr after fusion with EGCs (closed circles) or ESCs (open circles). 
Anticipated 50% levels of HpaII resistance are marked in gray, and the values shown are the 
mean and SE of three to five independent experiments. 
A second enzymatic approach was used to estimate the abundance of unmethylated cytosine 
at sites in the human genome before and after fusion. This relies on template digestion with 
HpaII, an enzyme that exclusively cuts unmodified cytosine (Figure 4A, right panel II). Using 
this strategy, we observed only modest increases in the level of unmodified cytosine detected 
at human ICRs (H19/IGF2, SNRPN/SNURF, and PEG3) that occurred exclusively in EGC-
derived heterokaryons (Figure 4E). However, substantial increases in HpaII sensitivity were 
detected at the human OCT4 promoter in both ESC- and EGC-derived samples (Figure 4C, 
right panel), consistent with Oct4 demethylation being critical for successful reprogramming 
to pluripotency (Simonsson and Gurdon, 2004). 
Independent Roles of Tet1 and Tet2 Hydroxylases in Pluripotent 
Reprogramming and Imprint Erasure 
The mammalian TET family comprises three members that share significant sequence 
homology (Münzel et al., 2011) and a capacity to regulate 5hmC levels (Tahiliani et al., 
2009). Tet1 and Tet2 proteins are expressed by pluripotent ESCs (Ito et al., 2010), regulated 
by Oct4 (Koh et al., 2011), and have been implicated in DNA demethylation during PGC 
development (Hackett et al., 2013). Tet3 is expressed in the preimplantation zygote, where it 
has been proposed to mediate the conversion of 5mC to 5hmC immediately after fertilization 
(Gu et al., 2011; Wossidlo et al., 2011). To investigate whether Tet1 and Tet2 enzymes were 
important for imprint erasure in our model system, we initially verified their expression in 
EGC lines. Mouse EGC lines expressed Tet1 and Tet2 proteins at levels that were 
comparable with ESCs, whereas differentiated controls such as mouse B cells (mB) did not 
(Figure 5A). RNAi-mediated depletion of Tet1 or Tet2 (shTet1 and shTet2, respectively) in 
EGCs resulted in the efficient and selective knockdown of Tet1 and Tet2 transcripts and 
proteins (Figures 5A and 5B) without provoking cell differentiation, as indicated by the 
sustained high level expression of Oct4 and Nanog and a lack of expression of 
differentiation-associated genes such as Bra and Gata4 (Figure 5B). 
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Distinct Roles of Tet Proteins in EGC-Mediated Heterokaryon Reprogramming 
(A) Western blot detection of Tet1 (upper), Tet2 (lower), Oct4, and Nanog proteins in whole-
cell extracts of mouse ESCs (mESCs), mouse B cells (mB), and mouse EGCs after 
transfection with shRNA for Tet1 (shTet1), for Tet2 (shTet2), or for control vector (shCtrl). 
Antibodies specific for Tet1, Oct4, Nanog, and Tubulin (a loading control) were used as 
described in the Supplemental Experimental Procedures. 
 
(B) qRT-PCR analysis of Tet1, Tet2, Oct4, Nanog, Brachyury (Bra), and Gata4 expression in 
mouse EGCs after transfection with shTet1 (white), shTet2 (gray), or control vector (black) 
where results are the mean and SD of four to five independent experiments and the values 
were calculated relative to UBC. 
 
(C) qRT-PCR analysis of OCT4, NANOG, and CRIPTO transcripts detected in hB cells 48 
hr after fusion with mouse EGCs transfected with control vector (black), shTet1 (white), or 
shTet2 (gray). The values shown are expressed relative to human GAPDH, normalized to 
shCtrl, and show the mean and SD of four to five independent experiments. *, p value < 0.05 
calculated with student t test. 
 
(D) Levels of 5hmC, estimated using the strategy depicted in I, at the human OCT4 locus in 
human B cells before (0 hr) and 48 hr and 72 hr after fusion with EGCs previously 
transfected with shCtrl (closed circles), shTet1 (open circles), or shTet2 (gray circles). 
Results are the mean and SE of four to five independent experiments. 
 
(E) Levels of 5hmC at H19/IGF2, PEG3, and SNRPN/SNURF ICRs as detailed above in (D). 
To investigate the contribution of Tet1 and Tet2 hydroxylases in EGC-mediated 
reprogramming and imprint erasure, we examined the capacity of Tet-depleted EGCs to 
reprogram human B cells after cell fusion. Knockdown of Tet2 in EGCs consistently reduced 
their reprogramming efficiency by about 50%, whereas Tet1 depletion had only a mild effect 
on human B cell reprogramming, as judged by the induction of a panel of human 
pluripotency genes (Figure 5C). Consistent with this, Tet1 depletion did not significantly 
impair the accumulation of 5hmC at the OCT4 locus, whereas Tet2 depletion resulted in a 
marked decrease in 5hmC levels (Figure 5D) and delayed loss of DNA methylation at the 
somatic OCT4 promoter (Figure S4A, left panel). These results allowed us to examine 
whether Tet1 was required for the conversion of 5mC to 5hmC at human imprinted domains 
in heterokaryons, independent of a requirement for this protein in pluripotent reprogramming. 
Although EGCs depleted of Tet1 were able to induce reprogramming of human B cells, they 
failed to induce 5hmC conversion at H19/IGF2, SNRPN/SNURF, and PEG3 ICRs, as judged 
by MspI protection (Figure 5E, upper panels). In addition, the depletion of Tet1 completely 
restored the equivalence of detection of maternal and paternal human H19/IGF2 alleles after 
bisulfite conversion (Figure S4B), directly implicating Tet1 in the biased amplification of 
paternal alleles that was detected previously. Depletion of Tet2, in contrast, had a mild effect 
on 5hmC accumulation at human ICRs (Figure 5E, lower panels), which probably reflects the 
diminished capacity of these cells to reprogram (Figure 5C). The levels of 5mC detected at 
ICRs in heterokaryons formed with Tet-depleted EGCs remained relatively constant over the 
first few days (Figure S4A, right panel), consistent with previous results showing that 
demethylation occurs later at these domains than at OCT4 and follows multiple rounds of cell 
division (Figures 1D and 1E). 
Given that DNA synthesis is an early event in both ESC and EGC fusion-based 
reprogramming (Tsubouchi et al., 2013) (Figure 2B), we asked whether 5hmC accumulation 
at ICRs required DNA synthesis. To address this, we fused hB cells with mEGCs and treated 
the resulting heterokaryons with inhibitors of DNA synthesis (aphidicolin or mimosine) for 
60 hr before assessing their impact on the induction of 5hmC relative to untreated controls. 
As shown in Figure S4C, treatment with either drug did not prevent 5hmC accumulation at 
either of the human ICRs tested (H19/IGF2 and PEG3) but comprehensively blocked the 
induction of human pluripotency-associated genes (Figure S4D). This result is consistent with 
DNA synthesis being required for pluripotent reprogramming (Tsubouchi et al., 2013), but it 
also suggests that the initial conversion of 5mC to 5hmC at human imprinted domains occurs 
through a DNA replication-independent mechanism. 
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Discussion 
Most imprinted domains contain a gametic differentially methylated region that acquires 
DNA methylation from the maternal germline in the oocyte. At least four domains, including 
H19 and Dlk1, are, however, known to carry a paternal imprint that is acquired in the male 
germline before birth (reviewed by John and Lefebvre, 2011). Here, we show that EGC lines 
can reset both maternal (Peg1, Peg3, and SNRPN) and paternal (H19 and Dlk1) imprints in B 
cells upon cellular fusion and provide fresh evidence that this is initiated as heterokaryons are 
formed. Not all mouse EGC lines share this property, and it is noteworthy that the female and 
male EGC clones used here (58G and 55G, respectively) were both isolated late during PGC 
development (E12.5) and require a low passage number and specialized culture conditions to 
retain their capacity to erase imprints after fusion. In practice, we have found that these cell 
lines begin to lose their ability to erase imprints in somatic cells by passage 30, despite a 
trend for these EGCs to become increasingly hypomethylated in culture (Figure S3F). Female 
ESCs and ESCs that lacked Dnmt1 or Dnmt3a and Dnmt3b also showed global 
hypomethylation but were consistently unable to erase methylation at ICRs in somatic 
partners. This suggests that EGCs isolated from PGCs at particular stages in development are 
uniquely able to target and impose demethylation at imprinted domains within the somatic 
genome. Because ESCs and EGCs express similar levels of Tet1, Tet2, Dnmt3a, and Dnmt3b 
proteins and show similar distributions of Dnmt1 and Uhrf1, the molecular details of this 
selective demethylation are not fully understood. 
Recent time-course studies of developing mouse PGCs have suggested that the progressive 
loss of DNA methylation in cells from E8 onward occurs in discrete temporal phases in 
which different genic and intergenic regions are affected (Seki et al., 2005; Guibert et al., 
2012). A loss of methylation at germline-specific genes and some somatic genes is detected 
relatively early (E8–E9), whereas imprinted domains such as Peg3, H19/Igf2, and Line1 
elements are targeted later (E9.5–E12.5) and mobile elements including intracisternal A-
particles and LTR-ERV1 retroelements remain relatively resistant to erasure (Hajkova et al., 
2002; Guibert et al., 2012). On the basis of kinetic observations, it was originally suggested 
that replication-dependent demethylation might operate early in PGC development, whereas 
replication-independent mechanisms function later as PGCs enter the gonads and G2 phase 
cells accumulate. However, recent studies of DNA methylation dynamics (Hackett et al., 
2013; Seisenberger et al., 2012) have suggested that high levels of Tet1 and Tet2 expression 
at E9.5–E10.5 could drive conversion of 5mC to 5hmC at ICRs and that reprogramming and 
imprint erasure may then occur by “replication-coupled” dilution (Kagiwada et al., 2013). 
Evidence linking putative hydroxylase and deaminase family members with DNA 
demethylation in vivo (Popp et al., 2010; Gu et al., 2011; Inoue and Zhang, 2011; Iqbal et al., 
2011) as well as in vitro (Rai et al., 2008; Bhutani et al., 2010) has been widely reported. 
Mice that are deficient in AID, Tet1, or Tet2 are, however, viable and largely fertile, although 
Tet1-null females were recently shown to have reduced numbers of germ cells and to fail to 
properly reactivate meiotic genes (Yamaguchi et al., 2012). This suggests that, although 
factors such as Tet1, Tet2, and AID might be nonessential or redundant during PGC 
development in vivo (Muramatsu et al., 2000; Dawlaty et al., 2011; Li et al., 2011), these 
factors may be indispensable for ICR remodeling in stringent in vitro assays. Consistent with 
this idea, the maternally methylated Peg1 and Peg3 ICRs were found to show similar 
hypomethylated profiles in mature sperm DNA obtained ex vivo from Tet1-null, 
heterozygous, and matched wild-type control mice (Figure S4E). 
The role of active (replication-independent) and passive (replication-dependent) DNA 
demethylation in global reprogramming has been widely contested. Initial claims that 
heterokaryon-mediated reprogramming by ESCs requires AID and occurs independently of 
DNA synthesis (Bhutani et al., 2010) have been called into question by recent studies 
(Foshay et al., 2012; Tsubouchi et al., 2013). Induced pluripotent stem cell (iPSC)-based 
investigations have shown that reprogramming is enhanced by cell division (Hanna et al., 
2009) and have indicated that Tet2 and Parp1 are required to direct 5hmC accumulation and 
subsequent transcriptional induction of pluripotency-associated genes (Doege et al., 2012). 
The in vitro reprogramming studies presented here show that depletion of Tet1 or Tet2 
reduces the efficiency of EGC-induced reprogramming of somatic cells. We identify two 
early steps in imprint erasure that are required to induce efficient locus remodeling and gene 
re-expression: precocious DNA synthesis and Tet1-mediated conversion of 5mC to 5hmC at 
ICRs. Given that drugs that block DNA polymerase activity prevented pluripotent gene re-
expression but only minimally affected 5hmC accumulation at ICRs, our study suggests that 
both active and passive mechanisms are required for efficient reprogramming and imprint 
erasure. 
We have shown that demethylation of pluripotency genes (such as Oct4) occurs relatively 
early after cell fusion and relies on Tet2. This is consistent with a recent report that shows 
that Tet2 is critical for iPSC-based reprogramming (Doege et al., 2012). On the other hand, 
our data indicate that the demethylation of ICRs in our reprogramming model depends on 
Tet1. Although detection of 5hmC at ICRs was initiated early after EGC fusion and did not 
require DNA polymerase activity, the acquisition of a hypomethylation state became evident 
only at later stages (days 7–12) after cells had undergone several rounds of cell division. 
These data suggest that Tet1 and Tet2 target different sites in the somatic genome (possibly 
through the Tet1 CXXC domain) (Tahiliani et al., 2009), although they do not exclude that 
somatic loci have variable thresholds of sensitivity to Tet-based remodeling. Given that 
5hmC is not recognized by the maintenance methyltransferase Dnmt1 (Hashimoto et al., 
2012), conversion of 5mC to 5hmC at specific sites in the somatic genome would be 
predicted to promote passive demethylation as hybrid cells divide. Thus, a two-step model for 
ICR remodeling could provide an explanation for the delay between 5hmC detection (at day 
2) and locus demethylation (at days 7–12) seen at mouse Peg1 and other ICRs studied herein. 
In this model, active (mediated by Tet1) and passive (mediated through DNA synthesis and 
cell division) mechanisms could contribute to imprint erasure in vitro. 
Our study shows that Tet1 and Tet2 proteins have distinct roles in pluripotent reprogramming 
induced by EGCs. Others have shown that prolonged depletion of Tet1 skews ESC 
differentiation toward trophectoderm and mesendoderm (Koh et al., 2011), whereas Tet2 
depletion skews hematopoietic differentiation (Ko et al., 2011) and impairs the trans-
differentiation of pre-B cells to macrophages (Kallin et al., 2012). Collectively, these and 
other studies (Ficz et al., 2011; Williams et al., 2011b; Wu et al., 2011) implicate Tet1 and 
Tet2 in balancing stem self-renewal and differentiation and in maintaining cellular identity. 
Our results suggest that the Tet1 and Tet2 proteins participate in cell-fusion-based 
remodeling of the somatic genome induced by EGCs. We show that Tet1 is important for 
initiating imprint erasure in this model system and provide evidence that this is achieved 
through a combination of DNA replication-dependent and -independent steps. 
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Experimental Procedures 
Cell Culture and Fusion 
Epstein-Barr-virus-transformed human B clones (hB), abelson-transformed mouse BOct4-GFP 
cells (mB), and mouse BOct4-GFP/Peg1-βgal cells (2RB) were cultured as described before 
(Pereira et al., 2008). Mouse EGCs (Tada et al., 1997), ESCs (ESL21), female (Pgk12) ESCs 
(Zvetkova et al., 2005), and mutant ESCs lacking Dnmt1 (Dnmt1−/−) (Li et al., 1992) or 
Dnmt3a and Dnmt3b (Dnmt3a/b−/−) (Chen et al., 2003) were cultured as previously described 
(Pereira et al., 2010). EGCs or ESCs were fused with either human B-lymphocytes, mB, or 
2RmB in a 1:1 ratio with the use of 50% polyethylene glycol (pH 7.4) (PEG 1500; Roche 
Diagnostics, Mannheim, Germany) as described previously (Pereira et al., 2010) and detailed 
in the Supplemental Experimental Procedures. 
Bisulfite Sequencing Analysis 
Bisulfite modification of DNA was carried out with the EZ DNA Methylation 
Kit (ZymoGenetics, Washington, USA) according to the manufacturer’s recommendations. 
PCR primers that specifically recognize bisulfite-converted mouse or human DNA are listed 
in the Supplemental Experimental Procedures. 
5hmC Detection 
Genomic DNA (10μg) was treated with (+T4) or without (−T4) T4 Phage β-
glucosyltransferase (T4-BGT; New England Biolabs, Massachusetts, USA) according to the 
manufacturer’s instructions and evaluated as detailed in the Supplemental Experimental 
Procedures. 
HpaII Resistance Assay 
Genomic DNA (10μg) was digested with 50 U of HpaII (NEB), 100 U of MspI (NEB), or no 
enzyme (mock digestion) at 37°C for 4 hr, followed by Proteinase K treatment for 30 min at 
40°C. The HpaII-resistant fraction was quantified by qPCR with the use of primers designed 
around at least one HpaII site, then normalized to a region lacking these sites (listed in the 
Supplemental Experimental Procedures) and the mock digestion control. 
Quantitative RT-PCR Analysis 
RNA extraction was performed as described previously (Pereira et al., 2010). Mouse- and 
human-specific primers are listed in the Supplemental Experimental Procedures. 
Tet1 and Tet2 Knockdown 
Short hairpin RNA (shRNA) sequences were cloned into pSuper.neo+GFP vectors 
(Oligoengine, Washington, USA). We electroporated 15 μg of empty (control) or shRNA-
containing vectors into 5 × 106 mouse EGCs by Amaxa Nucleofector 2b (Lonza, Basel, 
Switzerland). 
• shTet1: tgtagaccatcactgttcgac (Williams et al., 2011b) 
• shTet2: gctctgaacagtattcaaagc (Ito et al., 2010) 
GFP+ EGCs were sorted with fluorescence-activated cell sorting (FACS) 12 hr after 
electroporation and replated for 24 hr before being harvested and used for characterizations 
and fusion experiments. 
Western Blot Analysis 
Western blot analysis was performed as previously described (Pereira et al., 2010) and is 
detailed in the Supplemental Experimental Procedures. 
Immunofluoresence, BrdU, and X-Gal Staining 
BrdU incorporation and immunofluorescence detection was performed as described 
previously (Tsubouchi et al., 2013). X-gal staining was performed as detailed in the 
Supplemental Experimental Procedures. 
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